Canada - engelsk - Health Canada

pro doc limitee - triazolam - tablet - .25mg - triazolam .25mg - benzodiazepines

Canada - engelsk - Health Canada

prempharm inc - triazolam - tablet - 0.125mg - triazolam 0.125mg - benzodiazepines

Canada - engelsk - Health Canada

prempharm inc - triazolam - tablet - 0.25mg - triazolam 0.25mg - benzodiazepines

Canada - engelsk - Health Canada

mylan pharmaceuticals ulc - triazolam - tablet - 0.125mg - triazolam 0.125mg - benzodiazepines

Canada - engelsk - Health Canada

mylan pharmaceuticals ulc - triazolam - tablet - 0.25mg - triazolam 0.25mg - benzodiazepines

Japan - engelsk - すりの適正使用協議会 RAD-AR Council, Japan

kyowa pharmaceutical industry co., ltd - triazolam - pale purple tablet, major axis: approx. 8.0mm, minor axis: approx. 5.6mm, thickness: approx. 2.2mm

Japan - engelsk - すりの適正使用協議会 RAD-AR Council, Japan

kyowa pharmaceutical industry co., ltd - triazolam - pale blue tablet, major axis: approx. 8.0mm, minor axis: approx. 5.6mm, thickness: approx. 2.2mm

USA - engelsk - NLM (National Library of Medicine)

pharmacia & upjohn company llc - triazolam (unii: 1hm943223r) (triazolam - unii:1hm943223r) - triazolam 0.25 mg - halcion is indicated for the short-term treatment of insomnia (generally 7 to 10 days) in adults. halcion is contraindicated in: pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to psychiatric medications, including halcion, during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for psychiatric medications at 1-866-961-2388 or visiting online at https://womensmentalhealth.org/pregnancyregistry/ risk summary neonates born to mothers using benzodiazepines late in pregnancy have been reported to experience symptoms of sedation and/or neonatal withdrawal [see warnings and precautions (5.10) and ]. available data from published observational studies of pregnant women exposed to benzodiazepines do not report a clear association with benzodiazepines and major birth defects (see ) . the background risk of major birth defects and miscarriage for the indicated population is unknown. all pr

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - triazolam, quantity: 0.25 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; indigo carmine; povidone; sodium starch glycollate; colloidal anhydrous silica; sodium lauryl sulfate; magnesium stearate

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - triazolam, quantity: 0.125 mg - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; povidone; purified water; sodium starch glycollate; colloidal anhydrous silica; sodium lauryl sulfate; magnesium stearate